Healthcare

Pfizer Inc.

Symbol: PFE
27.25 €
+1.41%
KGV
35.4
Dividende
6.40%
Marktkap.
155.3 Mrd
52W Hoch
28.75 €
52W Tief
23.58 €

Live Chart

Über Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncolo

Aktuelle Finanznachrichten

Hinweis: Diese Daten dienen nur zur Information und stellen keine Anlageberatung dar. Aktualisiert: 19.08.2026 11:00
| YouTube